AGT and kidney disorder: As the upregulation of intrarenal RAS components correlates with fibrotic tissue injury in progressive kidney diseases [13,14,15], it has been previously proposed that urinary AngII could be a biomarker of intrarenal RAS activity [16]; albeit, it is currently difficult to measure the precise level of AngII in patients.